03-27-2014 When it comes to cancer prevention, adjuvant treatment, and survivorship, the integrative practitioner has a lot to offer. In this audio interview, leading oncology experts share their view of what is most compelling evidence regarding cancer development, progression, and treatment.
03-01-2014 With rates of cancer continuing to increase, the primary care physician is seeing more people who have or have had a cancer diagnosis. In this interview, Amy Loschert, ND, provides some key advice to healthcare practitioners who are not trained in oncology.
02-13-2014 Nearly all patients receiving broad-based chemotherapy will experience immunosuppression. Chemotherapy, by design, targets rapidly dividing cells. It does not discriminate between cancer cells and other rapidly dividing cells. Heather Zwickey, PhD, recently presented at the Oncology Association of Naturopathic Physicians (OncANP) annual conference on the topic of immunosuppression in patients undergoing chemotherapy. Natural Medicine Journal talked to Zwickey about this important oncology topic.
02-01-2014 In this interview with leading naturopathic oncologist, Timothy Birdsall, ND, FABNO, we discuss the past, present, and future of integrative oncology. Birdsall explains the role of the naturopathic physician in cancer care and describes why this team approach is important.
01-01-2014 The clinical efficacy of hydrogen breath testing is improving, and its use is expanding. In this interview with Craig Strasnick, COO of Commonwealth Laboratories, we discuss the procedure, practical applications, and future direction of hydrogen and methane analysis.
10-01-2013 Dr. Kristina Conner discusses the upcoming first annual conference presented by the Illinois Association of Naturopathic Physicians (ILANP).
10-01-2013 In this interview, program committee member Marcia Prenguber, ND, FABNO, describes the goals of the conference and provides a glimpse of what attendees can expect to learn.
09-01-2013 As a companion piece to our Q&A with M Mamadou, PhD, in the September 2013 NMJ Supplement, we asked Dr Mamadou to outline some specific digestive orders that can benefit from the use of supplemental digestive enzymes.
07-01-2013 Pain management expert Beth Darnall, PhD, discusses a wide variety of issues associated with opioid use, including advice on how practitioners can help their patients transition off their pain medications safely and effectively.
How Does Mineral Chelation Impact Bioavailability and Tolerability? A Conversation with Jonathan Bortz, MD
06-01-2013 Mineral absorption and tolerability are significant concerns in clinical practice. In this interview, Jonathan Bortz, MD, uses the example of iron to illustrate the impact that the 6-stage chelate process can have on bioavailability.
05-01-2013 Dr. Bradley Bush describes the connection between epinephrine, norepinephrine, and neurotransmitter synthesis in patients with poor adrenal function. Bush discusses the role of S-adenosyl-methionine in correcting underlying methylation imbalances in this patient population.
04-01-2013 Dr. Danielle Citrolo describes mechanisms of action, clinical research, interactions, and future applications for citicoline. She also explains how practitioners may consider using this therapeutic nutrient in clinical practice.
03-01-2013 In this interview, leading expert in environmental medicine and food sensitivities, Walter Crinnion, ND, compares and contrasts existing food-testing methods with a new kit healthcare practitioners can use. He also describes symptoms and prevalence of food sensitivities.
Addressing Underlying Anxiety in Today's Patient Population: An Interview with Lise Alschuler, ND, FABNO
03-01-2013 According to esteemed naturopathic oncologist Lise Alschuler, ND, FABNO, addressing issues of anxiety will help impact the success of therapeutic regimens used for other conditions. In this podcast, Alschuler discusses her top 3 most scientifically validated and clinically useful biological therapies for treating anxiety. She also makes the connection between stress and anxiety and talks about the important role the integrative practitioner can play in helping with address both.
02-01-2013 Greg Nigh, ND, LAc, refutes Dr. James Watson's hypothesis that antioxidants are detrimental in cancer care. He also explains how many of the mechanisms of cancer growth have been targets of integrative oncology focused growth control for quite some time.
02-01-2013 According to registered pharmacist and best-selling author, Suzy Cohen, probiotics affect gene activity in a positive and collaborative way. This podcast is sponsored by Essential Formulas Incorporated/Dr. Ohhira's Probiotics
01-01-2013 NMJ’s Medical Editor, Tina Kaczor, ND, FABNO, recently interviewed Valter Longo, PhD, Edna M. Jones professor in gerontology, professor in biological science, and director of the Longevity Institute, on his research in caloric restriction and fasting in cancer.
12-01-2012 Data regarding omega-3 fatty acid supplementation and cardiovascular health is conflicting. Donald Jump, PhD, describes his analysis that was published this year in the Journal of Lipid Research (Volume 53). He also clears up some of confusion and describes conclusions that can be made regarding the existing scientific data involving omega-3 fatty acids.
09-01-2012 In October the Society for Integrative Oncology (SIO) will host its 9th international conference in Albuquerque, NM. SIO President, Kara Kelly, MD, describes the agenda and discusses her thoughts on what the future holds for the practice of integrative oncology. The SIO's mission is to advance evidence-based, comprehensive, integrative healthcare to improve the lives of people affected by cancer.